Article

Ellex announces rebranding; introduces retina laser

Ellex Medical Laser Ltd., of Adelaide, Australia, announces it will establish Ellex as its worldwide brand name - consistent with its name on the Australian Stock Exchange. Ellex replaces the brand name Laserex on all products, and the company's U.S. and Japanese subsidiaries will also adopt the name.

Ellex Medical Laser Ltd., of Adelaide, Australia, announces it will establish Ellex as its worldwide brand name - consistent with its name on the Australian Stock Exchange. Ellex replaces the brand name Laserex on all products, and the company's U.S. and Japanese subsidiaries will also adopt the name.

In addition, Ellex is relocating its global headquarters responsible for global sales, marketing, and customer service to the San Francisco Bay area in the second half of 2006. The move is part of the company's strategy to be centrally located to its three main markets in North America, North Asia, and Europe. The headquarters will be under the direction of Ellex Chief Executive Officer Peter Falzon.

The company's manufacturing, engineering, and finance operations will remain in Adelaide.

In other news, Ellex introduces the Integre Duo solid-state red and green photocoaguator at the American Society of Cataract and Refractive Surgery meeting. Pending FDA clearance, the company expects the system to be commercially available in the United States in July.

The photocoagulator provides choice and versatility to ophthalmologists who treat challenging retinal conditions, according to the company.

"We have followed our customers' desire to integrate the clinical utility and performance of the existing ion argon-krypton lasers and not compromise those benefits when choosing a solid-state laser today," Falzon said. "The Integre Duo provides the benefits of both simultaneous true red and green wavelength selection in a compact solid-state design."

For more information, visit Ellex at Booth 2526.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.